PL1765863T3 - Związki oparte na peptydach - Google Patents
Związki oparte na peptydachInfo
- Publication number
- PL1765863T3 PL1765863T3 PL05752383T PL05752383T PL1765863T3 PL 1765863 T3 PL1765863 T3 PL 1765863T3 PL 05752383 T PL05752383 T PL 05752383T PL 05752383 T PL05752383 T PL 05752383T PL 1765863 T3 PL1765863 T3 PL 1765863T3
- Authority
- PL
- Poland
- Prior art keywords
- peptide
- based compounds
- angiogenesis
- optical imaging
- relates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 238000012634 optical imaging Methods 0.000 abstract 2
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20042523 | 2004-06-16 | ||
| EP05752383A EP1765863B1 (en) | 2004-06-16 | 2005-06-15 | Peptide-based compounds |
| PCT/NO2005/000210 WO2005123768A1 (en) | 2004-06-16 | 2005-06-15 | Peptide-based compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1765863T3 true PL1765863T3 (pl) | 2012-05-31 |
Family
ID=34979156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05752383T PL1765863T3 (pl) | 2004-06-16 | 2005-06-15 | Związki oparte na peptydach |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7897142B2 (pl) |
| EP (1) | EP1765863B1 (pl) |
| JP (1) | JP5280683B2 (pl) |
| CN (2) | CN1968963A (pl) |
| AT (1) | ATE538135T1 (pl) |
| BR (1) | BRPI0512209A (pl) |
| ES (1) | ES2376557T3 (pl) |
| PL (1) | PL1765863T3 (pl) |
| RU (1) | RU2393167C2 (pl) |
| WO (1) | WO2005123768A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL207834B1 (pl) * | 2001-07-10 | 2011-02-28 | Ge Healthcare As | Związki na bazie peptydów, ich zastosowanie oraz zawierająca je kompozycja farmaceutyczna |
| ES2358745T3 (es) * | 2004-11-22 | 2011-05-13 | Ge Healthcare As | Agentes de contraste para señalar matriz extracelular. |
| ITMI20050328A1 (it) | 2005-03-03 | 2006-09-04 | Univ Degli Studi Milano | Composti peptidomimetrici e preparazione di derivati biologicamente attivi |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| GB0718957D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| US8685370B2 (en) * | 2008-03-14 | 2014-04-01 | Visen Medical, Inc. | Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| US20100291706A1 (en) * | 2009-05-15 | 2010-11-18 | Millipore Corporation | Dye conjugates and methods of use |
| ES2398042T3 (es) * | 2009-10-21 | 2013-03-13 | Cyanagen Srl | Kit y procedimiento para el marcaje de biomoléculas |
| GB201010878D0 (en) | 2010-06-29 | 2010-08-11 | Ge Healthcare As | Dye compositiion and dye syntheses |
| JP2013534557A (ja) | 2010-06-29 | 2013-09-05 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 色素組成物及び色素合成法 |
| US9592307B2 (en) | 2012-07-20 | 2017-03-14 | Canon Kabushiki Kaisha | Compound and photoacoustic imaging contrast medium containing the compound |
| US20150258217A1 (en) * | 2012-10-04 | 2015-09-17 | The General Hospital Corporation | Methods of Synthesizing and Using Peg-Like Fluorochromes |
| RU2680068C2 (ru) * | 2013-09-02 | 2019-02-14 | Л'Ореаль | Способ окрашивания кератиновых волокон с применением катионных стириловых дисульфидных красителей и композиция, содержащая указанные красители |
| CN107022350A (zh) * | 2017-04-20 | 2017-08-08 | 深圳大学 | 一种荧光造影材料及其制备方法与应用 |
| CN107739528A (zh) * | 2017-09-30 | 2018-02-27 | 武汉工程大学 | 一种五肽改性菁染料化合物及其制备方法和应用 |
| DK3969063T3 (da) | 2019-05-13 | 2023-09-25 | Bracco Imaging Spa | Modificerede cyaninfarvestoffer og konjugater deraf |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4445065A1 (de) * | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung |
| CN1230441C (zh) | 2000-04-12 | 2005-12-07 | 安盛药业有限公司 | 结合整联蛋白的肽衍生物 |
| PL207834B1 (pl) * | 2001-07-10 | 2011-02-28 | Ge Healthcare As | Związki na bazie peptydów, ich zastosowanie oraz zawierająca je kompozycja farmaceutyczna |
| NO20033115D0 (no) | 2003-07-08 | 2003-07-08 | Amersham Health As | Peptid-baserte forbindelser |
-
2005
- 2005-06-15 RU RU2006144279/04A patent/RU2393167C2/ru not_active IP Right Cessation
- 2005-06-15 JP JP2007516412A patent/JP5280683B2/ja not_active Expired - Fee Related
- 2005-06-15 AT AT05752383T patent/ATE538135T1/de active
- 2005-06-15 BR BRPI0512209-0A patent/BRPI0512209A/pt not_active IP Right Cessation
- 2005-06-15 PL PL05752383T patent/PL1765863T3/pl unknown
- 2005-06-15 US US11/570,156 patent/US7897142B2/en not_active Expired - Fee Related
- 2005-06-15 EP EP05752383A patent/EP1765863B1/en not_active Not-in-force
- 2005-06-15 WO PCT/NO2005/000210 patent/WO2005123768A1/en active Application Filing
- 2005-06-15 ES ES05752383T patent/ES2376557T3/es active Active
- 2005-06-15 CN CNA2005800198740A patent/CN1968963A/zh active Pending
- 2005-06-15 CN CNA2005800273703A patent/CN101001870A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2376557T3 (es) | 2012-03-14 |
| US7897142B2 (en) | 2011-03-01 |
| RU2006144279A (ru) | 2008-07-27 |
| EP1765863A1 (en) | 2007-03-28 |
| JP2008504237A (ja) | 2008-02-14 |
| BRPI0512209A (pt) | 2008-02-19 |
| CN1968963A (zh) | 2007-05-23 |
| JP5280683B2 (ja) | 2013-09-04 |
| RU2393167C2 (ru) | 2010-06-27 |
| WO2005123768A1 (en) | 2005-12-29 |
| ATE538135T1 (de) | 2012-01-15 |
| US20080095715A1 (en) | 2008-04-24 |
| EP1765863B1 (en) | 2011-12-21 |
| CN101001870A (zh) | 2007-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1765863T3 (pl) | Związki oparte na peptydach | |
| WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
| NO20056055L (no) | Fluorescein-labelled peptides | |
| CY1115906T1 (el) | Ανθρωποποιημενα αντισωματα κατα του βητα αμυλοειδους | |
| ZA200706533B (en) | Use of cyanine dyes for the diagnosis of proliferative diseases | |
| EA201100231A1 (ru) | Диагностический анализ на основе антител | |
| NO20024932D0 (no) | Kontrastmiddel | |
| ATE551073T1 (de) | Markierte hgf-bindende peptide für bildgebung | |
| WO2011045415A3 (en) | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases | |
| EA200970923A1 (ru) | АНТИ-EpСАМ АНТИТЕЛО И ЕГО ПРИМЕНЕНИЕ | |
| WO2003006491A3 (en) | Peptide-based compounds for targeting intergin receptors | |
| ATE500844T1 (de) | Detektion der mcsp-oberflächenexpression einer zelle | |
| WO2009129311A3 (en) | Somatostatin receptor 2 antagonists | |
| BRPI0412986A (pt) | composto, método para o diagnóstico ou formação de imagem in vivo de uma doença ou condição associadas com a angiogênese, formulação radiofarmacêutica, método para a preparação de um composto, e, kit para a preparação de um peptìdeo radiofluorado | |
| AR050215A1 (es) | Metodo para diagnosticar enfermedades utilizando copeptina. | |
| EP2546649A3 (en) | Biomarkers for fatty liver disease and methods using the same | |
| GB0718967D0 (en) | Peptide imaging agents | |
| EA200701634A1 (ru) | Добавки к средствам для мытья тела | |
| EA200901142A1 (ru) | 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники | |
| GB0718957D0 (en) | Optical imaging agents | |
| TW200628171A (en) | Compounds for myocardial perfusion imaging | |
| CL2018000131A1 (es) | Inmunoconjugados de il22 | |
| NO20065806L (no) | Peptid-baserte forbindelser | |
| BRPI0922908A2 (pt) | "composição compreendendo pelo menos dois cicloalquilmeticonas diferentes e uso deste". | |
| SV2009003205A (es) | Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet) |